ALKBH5 and cancer: It is well known that aberrant expression of ALKBH5 both promote and suppress carcinogenesis based on cancer types, via post-transcriptional modulation of oncogenes or tumor suppressors in an m6A-dependent manner, resulting in alterations in cancer cell proliferation, migration, invasion, metastasis, drug resistance, and cancer immunity [66].